Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (13933)	7/3/2000 11:17:41 AM
From: Bluegreen	Read Replies (1) \| Respond to of 17367

George, you stated>>>>>>>>>Cacaito, I think you have helped people realize that cost is an important factor in determination of what will be used and when. It is clear to me that BPI will not be used for anything that a cheaper antibiotic can cure.<<<<<<<< You have to qualify that George. How many people take these new anti-inflammatory drugs when aspirin will do?? I could go on and on. Now what about more rapid and effective??? Why take something that will cure you BUT might take longer exposes you to more risk and may not kill resistant bugs????? What happens if it is shown your hospital stay and followup care is cheaper when using a new product???? What about legal liability issues when you choose the "cheaper" route??? George, when you or a loved one are faced with a GRAM NEG INFECTION..............what are YOU going to choose to do????